Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Medical Institutions Can Advertise from April 1
April 15, 2002
- Let the Change Be Your Friend: Mr Ogawa of Nippon Roche
April 15, 2002
- Sanofi-Synthelabo Looks for New Type of Partnership in Japan
April 15, 2002
- LDP Opposed to Experimental Deregulation in Healthcare Field
April 15, 2002
- Tamiflu Leads Relenza on Market for Anti-flu Drugs
April 15, 2002
- Copayment Hike to Reduce Patients' Visits to Hospitals: Survey
April 15, 2002
- Entering US Market to Change Business Style of Japanese Firms: Analyst
April 15, 2002
- Awareness of GL on COPD Low
April 15, 2002
- Janssen: Sales Up 28.7% to \41.3 Billion
April 15, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 15, 2002
- Kyowa Hakko's Dacarbazine Approved for Hodgkin's Disease
April 15, 2002
- Ain Pharmaciez, Imagawa Yakuhin to Merge This November
April 15, 2002
- Asahi Kasei's Toledomin Shows Steady Growth in Sales
April 15, 2002
- Sugi Pharmacy: Sales Exceed \50 Bil.
April 15, 2002
- BUSINESS NEWS IN BRIEF
April 15, 2002
- OCT NEWS IN BREIF
April 15, 2002
- WEBSITE NEWS
April 15, 2002
- WORLD NEWS IN BRIEF
April 15, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
April 15, 2002
- The 122nd Anniversary Meeting of the Pharmaceutical Society of Japan
April 15, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…